Market Value2,988,202,000
Total Holdings74
File Date2019-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
IMGN / ImmunoGen, Inc.
TNDM / Tandem Diabetes Care, Inc.
BMY / Bristol-Myers Squibb Company
SRPT / Sarepta Therapeutics, Inc.
CELG / Celgene Corp.
VCEL / Vericel Corporation
GBT / Global Blood Therapeutics Inc.
TCRR / Tcr2 Therapeutics Inc
QURE / uniQure N.V.
ADPT / Adaptive Biotechnologies Corporation
FTSV / Forty Seven, Inc.
AMED / Amedisys, Inc.
LHCG / LHC Group Inc
AVDR / New Age Alpha Trust - AVDR US LargeCap Leading ETF
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
GOSS / Gossamer Bio, Inc.
LOGC / ContextLogic Holdings Inc.
WVE / Wave Life Sciences Ltd.
EPZM / Epizyme Inc
FLXN / Horizon Funds - Horizon Flexible Income ETF
FATE / Fate Therapeutics, Inc.
ODT / Odonate Therapeutics Inc
SYRS / Syros Pharmaceuticals, Inc.
US62857M1053 / MyoKardia, Inc.
US29266S3040 / Endologix, Inc.
US014339AA35 / Alder Biopharmaceuticals Inc Bond
US0153511094 / Alexion Pharmaceuticals, Inc.
US74257L1089 / Principia Biopharma Inc.
INSP / Inspire Medical Systems, Inc.
AXNX / Axonics, Inc.
ANAB / AnaptysBio, Inc.
GTHX / G1 Therapeutics, Inc.
XNCR / Xencor, Inc.
/ Oxford Immunotec Global PLC
BOLD / Boundless Bio, Inc.
CMRX / Chimerix, Inc.
CSLT / Castlight Health Inc - Class B
NVRO / Nevro Corp.
JNCE / Jounce Therapeutics Inc
ADVM / Adverum Biotechnologies, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
EHTH / eHealth, Inc.
CLVS / Clovis Oncology Inc
98235T107 / Wright Medical Group N.V.
TCDA / Tricida Inc
GLYC / GlycoMimetics, Inc.
ESTA / Establishment Labs Holdings Inc.
OVID / Ovid Therapeutics Inc.
AKRO / Akero Therapeutics, Inc.
VAPO / Vapotherm, Inc.
TDOC / Teladoc Health, Inc.
US69354M1080 / PRA Health Sciences Inc
US28249H1041 / Eidos Therapeutics, Inc.
CBAY / CymaBay Therapeutics, Inc.
HZNP / Horizon Therapeutics Plc
FOLD / Amicus Therapeutics, Inc.
ELV / Elevance Health, Inc.
SDC / Smiledirectclub Inc - Class A
NVTA / Invitae Corporation
PSNL / Personalis, Inc.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
VKTX / Viking Therapeutics, Inc.
GMXAY / Genmab A/S
/ Array BioPharma, Inc.
BMRN / BioMarin Pharmaceutical Inc. Call
KRYS / Krystal Biotech, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
DCPH / Deciphera Pharmaceuticals, Inc.
UNH / UnitedHealth Group Incorporated
HCA / HCA Healthcare, Inc.
BMRN / BioMarin Pharmaceutical Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
CNC / Centene Corporation
NBIX / Neurocrine Biosciences, Inc.
DXCM / DexCom, Inc.
XERS / Xeris Biopharma Holdings, Inc.
LIVN / LivaNova PLC
SRRK / Scholar Rock Holding Corporation
JAZZ / Jazz Pharmaceuticals plc
PEN / Penumbra, Inc.
REPL / Replimune Group, Inc.
BCEL / Atreca, Inc.
HOOK / HOOKIPA Pharma Inc.
IGMS / IGM Biosciences, Inc.
ATRA / Atara Biotherapeutics, Inc.
RGNX / REGENXBIO Inc.
STXS / Stereotaxis, Inc.
ALLK / Allakos Inc.
STOK / Stoke Therapeutics, Inc.
GRTSQ / Gritstone bio, Inc.